Abstract:
OBJECTIVE:To assess, in the setting of routine clinical practice, rizatriptan's effectiveness in treating acute migraine at its onset versus in a later phase of the attack. BACKGROUND:Although the efficacy and tolerability of rizatriptan have been well documented in clinical trials, no information is available about the impact of the timing of medication use on clinical outcome. METHODS:Migraineurs were enrolled in a prospective study and treated with rizatriptan 10 mg for two migraine attacks. Patients reported how they used the medication and treatment outcomes via an interactive voice response system. Outcome variables assessed included: time to onset of headache relief, headache severity 2 hours postdose and whether or not patients became largely symptoms-free (including associated symptoms), and when they were able to resume normal activities. Episodes in which patients took rizatriptan immediately after experiencing headache were designated "early use" and those in which patients delayed treatment until their headaches evolved to become moderate or severe were designated as "delayed use." Generalized estimating equations were used to assess the impact of early drug use and to control for age, gender, drug formulation, use of other migraine prescription medications before taking rizatriptan, attack sequence, migraine attack frequency, and recent migraine severity. RESULTS:A total of 1919 migraineurs with 3450 migraine attack episodes were evaluated, of which 1369 episodes were early use and 2081 delayed use. Compared to delayed-use episodes, episodes wherein patients took rizatriptan early were 1.33 times more likely to be characterized by onset of headache relief within 30 minutes posttreatment (95% confidence interval [CI], 1.11 to 1.60), 1.32 times more likely to result in a largely symptom-free state (95% CI, 1.12 to 1.57), and 1.34 times more likely to be associated with a return to normal activities (95% CI, 1.13 to 1.58) within 1 hour posttreatment. No significant difference between early-use and delayed-use episodes was observed with respect to the likelihood of there being no or mild headache 2 hours posttreatment (odds ratio, 1.05; 95% CI, 0.90 to 1.24). CONCLUSIONS:Whether taken at headache onset or later in the attack, rizatriptan was equally effective in relieving acute migraine headache by 2 hours postdose. Taking rizatriptan at the onset of headache was associated with more rapid relief of headache and reversal of functional disability.
journal_name
Headachejournal_title
Headacheauthors
Hu XH,Raskin NH,Cowan R,Markson LE,Berger ML,United States Migraine Study Protocol (USMAP) Group.doi
10.1046/j.1526-4610.2002.02008.xkeywords:
subject
Has Abstractpub_date
2002-01-01 00:00:00pages
16-20issue
1eissn
0017-8748issn
1526-4610journal_volume
42pub_type
杂志文章相关文献
HEADACHE文献大全abstract:OBJECTIVE:To confirm the efficacy of rizatriptan 10 mg orally disintegrating tablet (ODT) for the elimination of migraine-associated nausea. BACKGROUND:Pooled studies of rizatriptan analyzing elimination of nausea as a secondary endpoint showed that 65% of rizatriptan patients reported elimination of nausea at 2 hours...
journal_title:Headache
pub_type: 杂志文章,多中心研究,随机对照试验
doi:10.1111/j.1526-4610.2007.00954.x
更新日期:2008-03-01 00:00:00
abstract:OBJECTIVES:To evaluate the safety and efficacy of ketamine-magnesium combination to reduce attacks in a series of patients with refractory chronic cluster headache (rCCH). BACKGROUND:Refractory chronic cluster headache (CCH) is a rare but highly debilitating condition that needs new treatment options. A previous publi...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/head.14005
更新日期:2020-11-01 00:00:00
abstract:OBJECTIVES:The aim of our study is to determine the prevalence of migraine in Provincial Center of Edirne. METHODS:A systematic random sample of 386 inhabitants over 14 years old were interviewed face to face. Diagnosis of migraine was based on the International Headache Society (IHS) classification. RESULTS:Migraine...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2005.05007.x
更新日期:2005-01-01 00:00:00
abstract::Genetic mutations of sporadic hemiplegic migraine (SHM) are mostly unknown. SHM pathophysiology relies on cortical spreading depression (CSD), which might be responsible for ischemic brain infarction. Cystic fibrosis (CF) is caused by a monogenic mutation of the chlorine transmembrane conductance regulator (CFTR), pos...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/head.13472
更新日期:2019-02-01 00:00:00
abstract:OBJECTIVE:To review the scope of the problem facing individuals with migraine who are under- or uninsured. In this first of a 2-part narrative review, we will explore migraine epidemiology and the challenges that face this vulnerable population. BACKGROUND:Implementation of the Affordable Care Act has improved access ...
journal_title:Headache
pub_type: 杂志文章,评审
doi:10.1111/head.13286
更新日期:2018-04-01 00:00:00
abstract::We studied 11 patients undergoing a routine lumbar puncture to determine if there were cerebrospinal fluid leaks at the puncture site and whether the maximum volume of leakage correlates with a lumbar puncture headache. Patients completed a headache questionnaire before and after the lumbar puncture. Limited magnetic ...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.1995.hed3507420.x
更新日期:1995-07-01 00:00:00
abstract:OBJECTIVE:To examine circadian and menstrual patterns of migraine frequency in order to identify properties of the putative migraine generator. METHODS:Analysis of circadian and menstrual migraine attack frequency distributions, using between-interval differences as estimates, at each time point, of the derivative of ...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2005.05134.x
更新日期:2005-07-01 00:00:00
abstract::Attacks of chronic paroxysmal hemicrania are prevented by the continuous administration of indomethacin. Sumatriptan, an agonist of 5-HT1-like receptors, has proven effective in the treatment of cluster headache attacks. There are clear clinical similarities between chronic paroxysmal hemicrania and cluster headache. ...
journal_title:Headache
pub_type: 杂志文章
doi:10.1046/j.1526-4610.1998.3803197.x
更新日期:1998-03-01 00:00:00
abstract::Verapamil is used mainly in cardiovascular diseases. High-dose verapamil (360-720 mg) is, however, currently the mainstay in the prophylactic treatment of cluster headache. The oral pharmacokinetics are variable. The pharmacodynamic effect of verapamil, the effect on blood pressure, also varies considerably among subj...
journal_title:Headache
pub_type: 杂志文章,评审
doi:10.1111/j.1526-4610.2008.01298.x
更新日期:2009-01-01 00:00:00
abstract:BACKGROUND:The progression and remission of migraine and the risk factors that determine the course of illness have been intensively studied for the past decade. METHODS:In this fourth paper in a series of methodological articles, we summarize crucial issues that influence studies of migraine clinical course, and sugg...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/head.12128
更新日期:2013-06-01 00:00:00
abstract:OBJECTIVE:To characterize adult patients with episodic migraine who achieved 100% response to galcanezumab treatment. BACKGROUND:Galcanezumab is a humanized monoclonal antibody that selectively binds to the calcitonin gene-related peptide (CGRP) and has demonstrated efficacy in reducing migraine headache days (MHD) in...
journal_title:Headache
pub_type: 杂志文章,随机对照试验
doi:10.1111/head.13427
更新日期:2018-10-01 00:00:00
abstract:BACKGROUND:Many children suffering from chronic headache and migraine present with comorbid functional disability, including physical, social, emotional, and academic activities. For children severely impaired by headache, intensive interdisciplinary pain rehabilitation treatment (IIPT) can improve functioning. However...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/head.13389
更新日期:2018-11-01 00:00:00
abstract::A 25-year-old man, subject to bouts of left supraorbital cluster headache on an annual basis over the previous 8 years, volunteered for MRI angiography during an active period. Studies were conducted before and during a typical cluster headache attack induced by alcohol. MRI angiography failed to show dilatation of th...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.1994.hed3408463.x
更新日期:1994-09-01 00:00:00
abstract:BACKGROUND:Migraine is a highly prevalent disorder that imposes an important burden of disability to patients and has social and economic impact in developed countries. A good screening tool for migraine diagnosis is useful to improve disease identification and therapeutic approaches, hopefully reducing the burden of m...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2009.01449.x
更新日期:2010-03-01 00:00:00
abstract::In order to obtain data regarding peripheral levels of beta-endorphin in head pain syndromes, we evaluated the plasma beta-endorphin secretory pattern in 12 adult male patients suffering from cluster headache. Blood samples were drawn every 2 hours for a 24-hour period, and in addition at 30-minute intervals for 120 m...
journal_title:Headache
pub_type: 杂志文章
doi:10.1046/j.1526-4610.1996.3610603.x
更新日期:1996-11-01 00:00:00
abstract::The recent publication of drug formularies by third-party payers has serious implications for the practice of medicine. These formularies list the medications for which the consumer can be reimbursed by the third-party payer. The most restrictive of the five formularies I have received lists only two agents for the tr...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.1995.hed3504225.x
更新日期:1995-04-01 00:00:00
abstract::The presence of postural, myofascial, and mechanical abnormalities in patients with migraine, tension-type headache, or both headache diagnoses was compared to a headache-free control sample. Twenty-four control subjects were obtained from a convenience sampling and each was matched by age and sex to three patients wi...
journal_title:Headache
pub_type: 杂志文章
doi:10.1046/j.1526-4610.1999.3901021.x
更新日期:1999-01-01 00:00:00
abstract::Vascular headaches, including migraine, cluster, and migrainous transformation to chronic daily headaches, are disabling. During and shortly after headache intervals, difficulties are reported in concentration, comprehension, and communication, not accounted for by nausea, photophobia, or sonophobia. These interfere w...
journal_title:Headache
pub_type: 杂志文章
doi:10.1046/j.1526-4610.2000.040008638.x
更新日期:2000-09-01 00:00:00
abstract:OBJECTIVE:To review and analyze published reports on the acute treatment of migraine headache with triptans, dihydroergotamine (DHE), and magnesium in emergency department, urgent care, and headache clinic settings. METHODS:MEDLINE was searched using the terms "migraine" and "emergency," and "therapy" or "treatment." ...
journal_title:Headache
pub_type: 杂志文章,评审
doi:10.1111/j.1526-4610.2011.02062.x
更新日期:2012-01-01 00:00:00
abstract::Pain has been considered as part of a defensive strategy whose specific role is to signal an immediate active danger to the organism. This definition fits well for acute pain. It does not work well, however, for chronic pain that is maintained even in absence of an ongoing, active threat. Currently, acute and chronic ...
journal_title:Headache
pub_type: 杂志文章,评审
doi:10.1111/j.1526-4610.2012.02244.x
更新日期:2012-10-01 00:00:00
abstract:BACKGROUND:Persistent migraine aura without infarction (PMA) is a rare condition that is defined as an aura that lasts longer than 1 week in absence of infarction. Two types of PMA have been distinguished, notably persistent primary visual disturbance (PPVD) and typical aura (TA). OBJECTIVES:This case-based review art...
journal_title:Headache
pub_type: 杂志文章,评审
doi:10.1111/head.12392
更新日期:2014-09-01 00:00:00
abstract:OBJECTIVES:To describe prophylactic and acute medication treatment patterns, including timing, medication type, and duration of use in migraine patients initiating prophylaxis. BACKGROUND:Patients with migraine can be treated with acute and prophylactic therapies. Current treatment options for migraine prophylaxis are...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/head.13157
更新日期:2017-10-01 00:00:00
abstract:OBJECTIVE:This cross-sectional study on a randomly drawn population sample of children and adolescents (n = 3399; aged 9 to 15) aimed at the assessment of patterns of associations between psychosocial variables and primary headache disorders like migraine (MIG) or tension-type headache. A headache-free group served as ...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2012.02210.x
更新日期:2012-10-01 00:00:00
abstract:OBJECTIVE:To investigate differences in cortical thickness in patients with persistent post-traumatic headache (PPTH) relative to healthy controls and to interrogate whether cortical morphology relates to headache burden (headache frequency, years with post-traumatic headache, PTH) in patients with PPTH. BACKGROUND:PT...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/head.13223
更新日期:2018-01-01 00:00:00
abstract:BACKGROUND:A cross-sectional descriptive study to determine the overall, age and gender specific prevalence, trigger factors and impact of headache and migraine on quality of life of students attending secondary schools in Benin City, Nigeria. METHODS:Six secondary schools were randomly selected from which students we...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2010.01776.x
更新日期:2010-11-01 00:00:00
abstract:BACKGROUND:Transient headache and neurologic deficits with cerebrospinal fluid lymphocytosis (HaNDL) is benign and self-limited, with neurologic deficits including sensory disturbance of one body side, aphasia, nausea/vomiting, weakness, decreased vision, homonymous hemianopsia, photophobia. Acute confusional state can...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/head.13238
更新日期:2018-03-01 00:00:00
abstract::Migraine shares a complex and poorly understood relationship with sleep. Patients consistently report poor sleep prior to migraine attacks and during them, identifying poor sleep as a migraine trigger. However, anecdotally, sleep is reported to serve a therapeutic role in terminating headache. Are the associations bet...
journal_title:Headache
pub_type: 杂志文章,评审
doi:10.1111/head.13358
更新日期:2018-07-01 00:00:00
abstract::Significant progress in molecular genetics has advanced our understanding of the genetic basis of migraine. The fundamentals of molecular genetics, and the recent advances in the field, are important for clinicians to understand, as they provide a foundation for critical appraisal of the literature, unprecedented insi...
journal_title:Headache
pub_type: 杂志文章,评审
doi:10.1111/head.12156
更新日期:2013-09-01 00:00:00
abstract:OBJECTIVE:A hallmark of migraine is photophobia. In mice, photophobia-like behavior is induced by calcitonin gene-related peptide (CGRP), a neuropeptide known to be a key player in migraine. In this study, we sought to identify sites within the brain from which CGRP could induce photophobia. DESIGN:We focused on the p...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/head.13917
更新日期:2020-10-01 00:00:00
abstract::We report two cases of sleep disturbances and perceptual disorder appearing in close temporal relationship with initiation of flunarizine therapy for migraine prophylaxis: these side effects disappeared after therapy interruption; resumption of the drug in one case was associated with symptom recurrence. ...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.1990.hed3002062.x
更新日期:1990-01-01 00:00:00